Lotus Pharmaceutical Co., Ltd. (1795)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
189. 00
-4.5
-2.3256%
NT$
80.36B Market Cap
20.79 P/E Ratio
- Div Yield
1.25M Volume
26.65 Eps
NT$ 193.5
Previous Close Want to track 1795 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lotus Pharmaceutical Co., Ltd. (1795) Statistics
Valuation metrics
Market Cap 80.36B
Enterprise value 99.84B
Trailing P/E (ttm) 12.71
Forward P/E -
PEG ratio -0.44
Price/Sales (ttm) 2.02
Price/Book (mrq) 2.03
Enterprise Value/Revenue 4.09
Enterprise Value/EBITDA 12.81
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.33M
Average volume (90 days) 2.21M
Price summary
52-Week low 170.5
52-Week high 369.5
Beta -
50-Day moving average 191.29
200-Day moving average 228.28
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 5.78
Trailing annual dividend yield 0.0307%
5-Year annual dividend yield -
Payout ratio 0.39
Dividend Date 5 Sep 2025
Ex-Dividend Date 11 Aug 2025
Last split factor 1,060:1,000
Last split Date 8 Sep 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.16%
Operating margin 0.25%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 93.98
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 14.82
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 23.84
Total debt (mrq) -
Total Debt/Equity (mrq) 2.36
Current ratio (mrq) 1.59%
Book value per share (mrq) 92.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
